InvestorsHub Logo

Raffis

10/06/21 7:11 PM

#145557 RE: arvitar #145556

We’ll see. They won’t risk infringing on Remdesivir. This company found the process to outsmart the virus’ defenses. GOVX ALSO DID IT, BETTER THAN EVERYONE ELSE. Stay here and watch what is going to happen.